TrialCancer medicine2017

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.

Richard J Gralla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.